Lucid Diagnostics (LUCD)
(Delayed Data from NSDQ)
$1.00 USD
+0.02 (2.19%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.00 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Lucid Diagnostics Inc. has a market cap of $105.87M, which represents its share price of $0.98 multiplied by its outstanding shares number of 108.19M. As a small-cap company, LUCD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LUCD 1.00 +0.02(2.19%)
Will LUCD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LUCD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUCD
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates
LUCD: What are Zacks experts saying now?
Zacks Private Portfolio Services
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know
Other News for LUCD
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 | ...
Lucid Diagnostics (LUCD) Awaits Medicare Coverage for EsoGuard Test
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
Lucid Diagnostics (LUCD) Set for Boost with Upcoming Medicare Approval
BTIG buyers of Lucid Diagnostics ahead of Medicare coverage